These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11106002)
1. The effect of suramin on bleomycin-induced lung injury. Lossos IS; Izbicki G; Or R; Goldstein RH; Breuer R Life Sci; 2000 Oct; 67(23):2873-81. PubMed ID: 11106002 [TBL] [Abstract][Full Text] [Related]
2. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters. Ben Yehuda A; Lossos IS; Or R; Ben Chetrit E; Goldstein RH; Conner MW; Breuer R Pulm Pharmacol Ther; 1997; 10(1):61-5. PubMed ID: 9344834 [TBL] [Abstract][Full Text] [Related]
3. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A. Lossos IS; Or R; Goldstein RH; Conner MW; Breuer R Exp Lung Res; 1996; 22(3):337-49. PubMed ID: 8792125 [TBL] [Abstract][Full Text] [Related]
4. The effect of enoxaparin on bleomycin-induced lung injury in mice. Laxer U; Lossos IS; Gillis S; Or R; Christensen TG; Goldstein RH; Breuer R Exp Lung Res; 1999 Sep; 25(6):531-41. PubMed ID: 10533678 [TBL] [Abstract][Full Text] [Related]
5. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury. Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R Respiration; 2001; 68(2):169-77. PubMed ID: 11287832 [TBL] [Abstract][Full Text] [Related]
6. Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2. Breuer R; Lossos IS; Or R; Krymsky M; Dagan A; Yedgar S Life Sci; 1995; 57(16):PL237-40. PubMed ID: 7564888 [TBL] [Abstract][Full Text] [Related]
7. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734 [TBL] [Abstract][Full Text] [Related]
8. Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis. El-Mafarjeh E; Martins GHC; Probst JJ; Santos-Dias A; Oliveira-Junior MC; de Barros MP; de Oliveira LVF; de Andrade LD; da Palma RK; Moraes-Ferreira R; de Camargo Hizume-Kunzler D; Bachi ALL; Vieira RP Oxid Med Cell Longev; 2020; 2020():4302608. PubMed ID: 33123311 [TBL] [Abstract][Full Text] [Related]
9. Bleomycin-induced lung injury is enhanced by interferon-alpha. Berkman N; Goldstein RH; Breuer R Life Sci; 1997; 60(26):PL415-21. PubMed ID: 9199490 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice. Lossos IS; Or R; Ginzburg V; Christensen TG; Mashriki Y; Breuer R Respiration; 2002; 69(4):344-9. PubMed ID: 12169749 [TBL] [Abstract][Full Text] [Related]
11. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis. Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074 [TBL] [Abstract][Full Text] [Related]
12. Halofuginone does not reduce fibrosis in bleomycin-induced lung injury. Tzurel A; Segel MJ; Or R; Goldstein RH; Breuer R Life Sci; 2002 Aug; 71(14):1599-606. PubMed ID: 12137906 [TBL] [Abstract][Full Text] [Related]
13. Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice. Izbicki G; Or R; Christensen TG; Segel MJ; Fine A; Goldstein RH; Breuer R Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1110-6. PubMed ID: 12376365 [TBL] [Abstract][Full Text] [Related]
14. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence. Giri SN; Hyde DM Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354 [TBL] [Abstract][Full Text] [Related]
15. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice. Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157 [TBL] [Abstract][Full Text] [Related]
16. Liposome encapsulation improves the effect of antifibrotic agent in rat lung fibrosis. Poiani GJ; Greco M; Choe JK; Fox JD; Riley DJ Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1623-7. PubMed ID: 7524983 [TBL] [Abstract][Full Text] [Related]
17. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies. Kilinç C; Ozcan O; Karaöz E; Sunguroğlu K; Kutluay T; Karaca L J Basic Clin Physiol Pharmacol; 1993; 4(3):249-69. PubMed ID: 8679519 [TBL] [Abstract][Full Text] [Related]
18. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice]. Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852 [TBL] [Abstract][Full Text] [Related]
19. Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis. Greco MJ; Kemnitzer JE; Fox JD; Choe JK; Kohn J; Riley DJ; Poiani GJ Am J Respir Crit Care Med; 1997 Apr; 155(4):1391-7. PubMed ID: 9105084 [TBL] [Abstract][Full Text] [Related]
20. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung. Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]